This result suggests that the identification of tumor γ-H2AX alone or combined evaluation of γ-H2AX/EGFR/HIF-1α levels as a new prognostic marker in patients with HCC after LT. The gene discussed is EGFR; the disease is hepatocellular carcinoma.